KLF4 and breast cancer: AGPAT9 inhibits breast cancer cell proliferation, migration and invasion both in vitro and in vivo through the KLF4/Homo sapiens longevity assurance homolog 2 of yeast LAG1 (LASS2)/ vacuolar-H+-ATPase (V-ATPase) signaling pathway [33].